This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: The Innovations of Jozef B. Thijssen: A Beacon in Pharmaceutical Research
Introduction
Jozef B. Thijssen, located in Kasterlee, Belgium, is a distinguished inventor in the pharmaceutical field. With a focus on innovative treatments against microbial infections, he holds a patent that underscores his contribution to modern medicine. His work is essential to advancing therapeutic strategies for battling diseases caused by fungi and bacteria in warm-blooded animals.
Latest Patents
Thijssen's notable patent includes the development of novel compounds such as [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles. This patent specifically focuses on their anti-microbial activity, offering compositions designed to inhibit and eliminate the development of harmful fungi and bacteria in afflicted warm-blooded animals.
Career Highlights
Jozef B. Thijssen is currently affiliated with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson renowned for its commitment to innovation in healthcare. His research plays a significant role in the ongoing development of effective medical solutions.
Collaborations
Throughout his career, Thijssen has collaborated with notable colleagues, including Jan Heeres and Leo J. Backx. These partnerships reflect a strong commitment to advancing medical science and underscore the collaborative spirit inherent in innovative research environments.
Conclusion
Jozef B. Thijssen's contributions to the pharmaceutical industry illustrate the importance of innovation in addressing critical health challenges. Through his patent and continued work at Janssen Pharmaceutica NV, he is paving the way for new methods of combating microbial diseases, showcasing the impactful role inventors play in improving public health.